Skip to content

Nasdaq · CIK 0001528115

ANNX Annexon, Inc.

Insider trading from SEC Form 4. Last filing 17 d ago. Close $4.02 on Oct 9, 2026, +50% from the 52-week low and -42% from the high.

Last 90 days

Net insider value
+$100k
more bought than sold
Buys
1
$100k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company

Price and insider trades, last year

ANNXOct 9, 2026 · close 4.02

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Annexon, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
46ModerateDouglas Love
PRESIDENT AND CEO
buy
$100k
26,065 shares
+7%+42% from low-45% from high
53ModerateJung Choi
director
buy
$138k
33,000 shares
-+199% from low-25% from high
27WeakWilliam H. Carson
director
buy
$18k
4,115 shares
+9%+199% from low-25% from high
67NotableMuneer A Satter
director
buy
$3.6M
822,613 shares
+9%+209% from low-22% from high
69NotableMuneer A Satter
director
buy
$5.1M
1,500,000 shares
+20%+119% from low-45% from high
16WeakWilliam H. Carson
director
buy
$13k
4,115 shares
+10%+112% from low-61% from high
16WeakWilliam H. Carson
director
buy
$13k
4,115 shares
+11%+121% from low-60% from high
16WeakWilliam H. Carson
director
buy
$8,600
4,115 shares
+12%+50% from low-73% from high
16WeakWilliam H. Carson
director
buy
$9,999
4,115 shares
+14%+88% from low-66% from high
30WeakMichael Overdorf
EVP & CHIEF BUSINESS OFFICER
sell
$2,226
853 shares
-1%+89% from low-66% from high
37WeakJennifer Lew
EVP & CHIEF FINANCIAL OFFICER
sell
$2,882
1,117 shares
-1%+89% from low-66% from high
30WeakTed Yednock
EVP & CHIEF INNOVATION OFFICER
sell
$2,879
1,116 shares
-1%+89% from low-66% from high
11WeakWilliam H. Carson
director
buy
$10k
4,115 shares
+16%+74% from low-69% from high
30WeakDean Richard Artis
EVP & CHIEF SCIENTIFIC OFFICER
sell
$16k
5,515 shares
-6%0% from low-65% from high
37WeakJennifer Lew
EVP & CHIEF FINANCIAL OFFICER
sell
$20k
6,912 shares
-8%0% from low-65% from high
30WeakMichael Overdorf
EVP & CHIEF BUSINESS OFFICER
sell
$20k
6,618 shares
-7%0% from low-65% from high
35WeakTed Yednock
EVP & CHIEF INNOVATION OFFICER
sell
$24k
8,345 shares
-12%0% from low-65% from high
35WeakJamie Dananberg
CHIEF MEDICAL OFFICER
sell
$16k
5,521 shares
-14%0% from low-65% from high
30WeakMichael Overdorf
EVP & CHIEF BUSINESS OFFICER
sell
$4,261
1,425 shares
-2%+0% from low-61% from high
30WeakTed Yednock
EVP & CHIEF INNOVATION OFFICER
sell
$5,331
1,783 shares
-2%+0% from low-61% from high
37WeakJennifer Lew
EVP & CHIEF FINANCIAL OFFICER
sell
$5,322
1,786 shares
-2%+0% from low-61% from high
40ModerateDouglas Love
PRESIDENT AND CEO
sell
$15k
5,021 shares
-1%+0% from low-61% from high
3WeakWilliam H. Carson
director
buy
$17k
3,200 shares
+14%-
0WeakTed Yednock
EVP & CHIEF INNOVATION OFFICER
sell
$40k
5,408 shares
-7%-

Transactions

The last 54 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 24, 2026Douglas Love
PRESIDENT AND CEO
POpen-market purchase
Common Stock
+26,065$3.83$100k390,47617 d ago
Dec 1, 2025Jung Choi
director
POpen-market purchase
Common Stockindirect: By Trust
+33,000$4.19$138k33,000Dec 3, 2025
Dec 1, 2025William H. Carson
director
POpen-market purchase
Common Stock10b5-1
+4,115$4.47$18k50,290Dec 3, 2025
Nov 20, 2025Muneer A Satter
director
POpen-market purchase
Common Stockindirect: See footnote
+400,000$4.48$1.8M9,306,024Nov 21, 2025
Nov 21, 2025Muneer A Satter
director
POpen-market purchase
Common Stockindirect: See footnote
+422,613$4.28$1.8M9,728,637Nov 21, 2025
Nov 17, 2025Muneer A Satter
director
POpen-market purchase
Common Stockindirect: See footnote
+500,000$2.99$1.5M7,906,024Nov 19, 2025
Nov 18, 2025Muneer A Satter
director
POpen-market purchase
Common Stockindirect: See footnote
+500,000$3.18$1.6M8,406,024Nov 19, 2025
Nov 19, 2025Muneer A Satter
director
POpen-market purchase
Common Stockindirect: See footnote
+500,000$3.94$2.0M8,906,024Nov 19, 2025
Oct 30, 2025William H. Carson
director
POpen-market purchase
Common Stock10b5-1
+4,115$3.17$13k46,175Oct 31, 2025
Sep 30, 2025William H. Carson
director
POpen-market purchase
Common Stock10b5-1
+4,115$3.05$13k42,060Oct 2, 2025
Sep 2, 2025William H. Carson
director
POpen-market purchase
Common Stock10b5-1
+4,115$2.09$8,60037,945Sep 4, 2025
Jul 30, 2025William H. Carson
director
POpen-market purchase
Common Stock10b5-1
+4,115$2.43$9,99933,830Aug 1, 2025
Jul 14, 2025Ted Yednock
EVP & CHIEF INNOVATION OFFICER
SOpen-market sale
Common Stock
-1,116$2.58$2,879105,084Jul 16, 2025
Jul 14, 2025Jennifer Lew
EVP & CHIEF FINANCIAL OFFICER
SOpen-market sale
Common Stock
-1,117$2.58$2,882121,616Jul 16, 2025
Jul 14, 2025Michael Overdorf
EVP & CHIEF BUSINESS OFFICER
SOpen-market sale
Common Stock
-853$2.61$2,226130,689Jul 16, 2025
Jun 30, 2025William H. Carson
director
POpen-market purchase
Common Stock10b5-1
+4,115$2.46$10k29,715Jul 1, 2025
Jun 5, 2025Bettina M. Cockroft
director
AGrant or award
Stock Option (Right to Buy)derivative
+55,000$0.00$055,000Jun 9, 2025
Jun 5, 2025William A Jones Jr
director
AGrant or award
Stock Option (Right to Buy)derivative
+55,000$0.00$055,000Jun 9, 2025
Jun 5, 2025Jung Choi
director
AGrant or award
Stock Option (Right to Buy)derivative
+55,000$0.00$055,000Jun 9, 2025
Jun 5, 2025William H. Carson
director
AGrant or award
Stock Option (Right to Buy)derivative
+55,000$0.00$055,000Jun 9, 2025
Jun 5, 2025William D. Waddill
director
AGrant or award
Stock Option (Right to Buy)derivative
+55,000$0.00$055,000Jun 9, 2025
Jun 5, 2025Muneer A Satter
director, owner
AGrant or award
Stock Option (Right to Buy)derivative
+55,000$0.00$055,000Jun 9, 2025
Jun 5, 2025Thomas G Wiggans
director
AGrant or award
Stock Option (Right to Buy)derivative
+55,000$0.00$055,000Jun 9, 2025
Feb 27, 2024Jamie Dananberg
CHIEF MEDICAL OFFICER
AGrant or award
Common Stock
+44,963$0.00$078,442Mar 3, 2025
Feb 27, 2024Jennifer Lew
EVP & CHIEF FINANCIAL OFFICER
AGrant or award
Common Stock
+44,963$0.00$0122,733Mar 3, 2025
Feb 27, 2024Ted Yednock
EVP & CHIEF INNOVATION OFFICER
AGrant or award
Common Stock
+44,963$0.00$0106,200Mar 3, 2025
Feb 27, 2024Michael Overdorf
EVP & CHIEF BUSINESS OFFICER
AGrant or award
Common Stock
+44,963$0.00$0131,542Mar 3, 2025
Feb 27, 2024Dean Richard Artis
EVP & CHIEF SCIENTIFIC OFFICER
AGrant or award
Common Stock
+44,963$0.00$0128,777Mar 3, 2025
Feb 27, 2025Douglas Love
PRESIDENT AND CEO
AGrant or award
Stock Option (Right to Buy)derivative
+1,300,000$0.00$01,300,000Mar 3, 2025
Feb 27, 2025Jamie Dananberg
CHIEF MEDICAL OFFICER
AGrant or award
Stock Option (Right to Buy)derivative
+228,225$0.00$0228,225Mar 3, 2025
Feb 27, 2025Dean Richard Artis
EVP & CHIEF SCIENTIFIC OFFICER
AGrant or award
Stock Option (Right to Buy)derivative
+272,575$0.00$0272,575Mar 3, 2025
Feb 27, 2025Michael Overdorf
EVP & CHIEF BUSINESS OFFICER
AGrant or award
Stock Option (Right to Buy)derivative
+272,575$0.00$0272,575Mar 3, 2025
Feb 27, 2025Ted Yednock
EVP & CHIEF INNOVATION OFFICER
AGrant or award
Stock Option (Right to Buy)derivative
+272,575$0.00$0272,575Mar 3, 2025
Feb 27, 2025Jennifer Lew
EVP & CHIEF FINANCIAL OFFICER
AGrant or award
Stock Option (Right to Buy)derivative
+272,575$0.00$0272,575Mar 3, 2025
Feb 18, 2025Dean Richard Artis
EVP & CHIEF SCIENTIFIC OFFICER
SOpen-market sale
Common Stock
-5,515$2.97$16k83,814Feb 20, 2025
Feb 18, 2025Jennifer Lew
EVP & CHIEF FINANCIAL OFFICER
SOpen-market sale
Common Stock
-6,912$2.92$20k77,770Feb 20, 2025
Feb 18, 2025Michael Overdorf
EVP & CHIEF BUSINESS OFFICER
SOpen-market sale
Common Stock
-6,618$2.95$20k86,579Feb 20, 2025
Feb 18, 2025Ted Yednock
EVP & CHIEF INNOVATION OFFICER
SOpen-market sale
Common Stock
-8,345$2.91$24k61,237Feb 20, 2025
Feb 18, 2025Jamie Dananberg
CHIEF MEDICAL OFFICER
SOpen-market sale
Common Stock
-5,521$2.96$16k33,479Feb 20, 2025
Feb 13, 2025Jennifer Lew
EVP & CHIEF FINANCIAL OFFICER
SOpen-market sale
Common Stock
-1,786$2.98$5,32284,682Feb 18, 2025
Feb 13, 2025Michael Overdorf
EVP & CHIEF BUSINESS OFFICER
SOpen-market sale
Common Stock
-1,425$2.99$4,26193,197Feb 18, 2025
Feb 13, 2025Douglas Love
PRESIDENT AND CEO
SOpen-market sale
Common Stock
-5,021$2.95$15k351,554Feb 18, 2025
Feb 13, 2025Ted Yednock
EVP & CHIEF INNOVATION OFFICER
SOpen-market sale
Common Stock
-1,783$2.99$5,33169,582Feb 18, 2025
Jan 9, 2025William A Jones Jr
director
AGrant or award
Stock Option (Right to Buy)derivative
+88,000$0.00$088,000Jan 10, 2025
Jan 6, 2025Douglas Love
PRESIDENT AND CEO
MOption exercise
Common Stock
+37,994$1.41$54k356,575Jan 8, 2025
Jan 6, 2025Douglas Love
PRESIDENT AND CEO
MOption exercise
Stock Option (Right to Buy)derivative
-37,994$0.00$00Jan 8, 2025
Dec 2, 2024William H. Carson
director
POpen-market purchase
Common Stock10b5-1
+3,200$5.33$17k25,600Dec 4, 2024
Oct 30, 2024Douglas Love
PRESIDENT AND CEO
MOption exercise
Common Stock
+78,399$1.85$145k274,520Nov 1, 2024
Oct 30, 2024Douglas Love
PRESIDENT AND CEO
MOption exercise
Common Stock
+36,050$1.85$67k310,570Nov 1, 2024
Oct 30, 2024Douglas Love
PRESIDENT AND CEO
MOption exercise
Stock Option (Right to Buy)derivative
-78,399$0.00$00Nov 1, 2024
Oct 30, 2024Douglas Love
PRESIDENT AND CEO
MOption exercise
Stock Option (Right to Buy)derivative
-36,050$0.00$00Nov 1, 2024
Oct 15, 2024Ted Yednock
EVP & CHIEF INNOVATION OFFICER
MOption exercise
Common Stock10b5-1
+5,408$1.85$10k76,773Oct 17, 2024
Oct 15, 2024Ted Yednock
EVP & CHIEF INNOVATION OFFICER
SOpen-market sale
Common Stock10b5-1
-5,408$7.41$40k71,365Oct 17, 2024
Oct 15, 2024Ted Yednock
EVP & CHIEF INNOVATION OFFICER
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-5,408$0.00$030,646Oct 17, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ANNX insider trading: Annexon, Inc. | InsiderTell